European Industry Backs Biosimilars ‘Scorecards’

Ratings Provide Analyses Of Biosimilar Policies In 12 Countries

Medicines for Europe and IQVIA have partnered to test biosimilar sustainability in 12 European countries by issuing scorecards that measure the contribution of a country’s biosimilar policies to health systems.

Scorecards
‘Scorecards’ prove that biosimilars are a win for patients, policymakers and healthcare systems across Europe • Source: Shutterstock

More from Biosimilars

More from Products